Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: agiak who wrote (1778)	11/12/1998 1:26:00 AM
From: CHIP HUNTER	Respond to of 3576

I'm not sure agiak..... I will try to find out though.

To: agiak who wrote (1778)	11/12/1998 1:34:00 AM
From: zoya	Respond to of 3576

THE 4 MILLION FIGURE IS FROM HERE: <<Contract revenues were $1.5 million and $3.7 million for the three and six months ended June 30, 1998, respectively, compared to $2.2 million for each of the comparable periods in 1997. Contract revenues in 1998 were from research support payments under the Company's collaborative agreements with Pharmacia & Upjohn (the "Pharmacia & Upjohn Agreement") and Kyowa Hakko Kogyo, Co. Ltd. (the "Kyowa Hakko Agreement"). Research support payments of $1.0 million and $4.0 million under the Kyowa Hakko Agreement were received in April 1998 and 1997, respectively. The Pharmacia & Upjohn Agreement was signed in March 1997 and the Company received its first quarterly research support payment of $1.25 million in April 1997. The Company recognizes revenue as related research and development costs are incurred under the collaborative agreements. Contract revenues are expected to decrease as a result of reduced research funding under the Kyowa Hakko Agreement.>> THE NUMBER OF SHARES HELD BY PHARMACIA IS: <<Pharmacia & Upjohn S.p.A. has agreed not to sell the 696,787 shares held by it until April 2000,>> FOLLOWING IS THE LINK TO THE 10Q sec.yahoo.com